Kinexum, an international healthcare consulting group, specializes in regulatory strategy, clinical development, and commercialization. With a team of former senior FDA and industry experts, Kinexum offers comprehensive services in regulatory, clinical, manufacturing, and commercialization fields. Over the past decade, the group has assisted more than 300 companies worldwide, including in Europe, Asia, Australia, and the Americas. Known for delivering high-impact solutions across various therapeutic areas, Kinexum's in-house medical expertise spans diabetes, cardiology, immunology, oncology, and gastroenterology. The group's capabilities extend to pharmaceuticals, biotechnology, medical devices, diagnostics, botanicals, and nutraceuticals, leveraging a global network for clinical and regulatory strategy, pharmacology, toxicology, and other key areas to efficiently achieve valuation milestones.